Matthew K. Szot, Director at INVO Bioscience, Inc. (INVO), bought 14,474 shares at $0.95 ($14K) on 2022-06-01, disclosed to the SEC on 2022-06-03.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| SNES | SELL | 2025-11-17 | $3 | — | Filing → |
| CVKD | SELL | 2025-10-28 | $50K | — | Filing → |
| CVKD | SELL | 2025-10-14 | $49K | — | Filing → |